Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC35D3 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | GADD45G | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | TXNDC16 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | CENPV | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-06 |
mRNA | PEX11B | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | ZNF224 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | RHOJ | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-06 |
mRNA | OR52N4 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | NPIPA1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |